{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:53:10Z","timestamp":1767383590404,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01HD071804"],"award-info":[{"award-number":["5R01HD071804"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.contraception.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T13:16:31Z","timestamp":1518182191000},"page":"8-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A systematic review of contraceptive continuation among women living with HIV"],"prefix":"10.1016","volume":"98","author":[{"given":"Catherine S.","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy C.","family":"Anderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Landon","family":"Myer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Petro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Joint United Nations Programme for HIV\/AIDS (UNAIDS)","key":"10.1016\/j.contraception.2018.02.002_bb0005"},{"key":"10.1016\/j.contraception.2018.02.002_bb0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00126334-200004150-00007","article-title":"High HIV incidence and prevalence among young women in rural South Africa: developing a cohort for intervention trials","volume":"23","author":"Wilkinson","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2018.02.002_bb0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/COH.0b013e32832c7d10","article-title":"HIV in adolescents in sub-Saharan Africa","volume":"4","author":"Cowan","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"10.1016\/j.contraception.2018.02.002_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000229","article-title":"Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in sub-Saharan Africa: a cohort study","volume":"7","author":"Myer","year":"2010","journal-title":"PLoS Med"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2018.02.002_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10461-008-9371-7","article-title":"Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda","volume":"13","author":"Maier","year":"2009","journal-title":"AIDS Behav"},{"issue":"2","key":"10.1016\/j.contraception.2018.02.002_bb0030","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/QAI.0000000000000279","article-title":"IeDEA West Africa collaboration. Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 west African countries","volume":"67","author":"Burgos-Soto","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.contraception.2018.02.002_bb0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1570162X11311020008","article-title":"Reproductive health and family planning needs among HIV-infected women in sub-Saharan Africa","volume":"11","author":"Sarnquist","year":"2013","journal-title":"Curr HIV Res"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2018.02.002_bb0040","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.aids.0000363773.83753.27","article-title":"Fertility preferences and the need for contraception among women living with HIV: the basis for a joint action agenda","volume":"23","author":"Johnson","year":"2009","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2018.02.002_bb0045","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/QAI.0b013e3181bbc818","article-title":"Impact of HIV treatment scale-up on women's reproductive health care and reproductive rights in Southern Africa","volume":"52","author":"Myer","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2018.02.002_bb0050","article-title":"Integration of HIV\/AIDS services with maternal, neonatal and child health, nutrition, and family planning services","volume":"9","author":"Lindegren","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2018.02.002_bb0055","first-page":"ii48","article-title":"What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs","volume":"86","author":"Mahy","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.contraception.2018.02.002_bb0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.olq.0000194602.01058.e1","article-title":"The value of contraception to prevent perinatal HIV transmission","volume":"33","author":"Reynolds","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.contraception.2018.02.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007691","article-title":"The contribution of family planning towards the prevention of vertical HIV transmission in Uganda","volume":"4","author":"Hladik","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2018.02.002_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/COH.0b013e3283632bd7","article-title":"The role of family planning in elimination of new pediatric HIV infection","volume":"8","author":"Wilcher","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.contraception.2018.02.002_bb0075","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2471\/BLT.09.065102","article-title":"Integrating family planning into Ethiopian voluntary testing and counselling programmes","volume":"87","author":"Gillespie","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.contraception.2018.02.002_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1758-2652-13-26","article-title":"Linking sexual and reproductive health and HIV interventions: a systematic review","volume":"13","author":"Kennedy","year":"2010","journal-title":"J Int AIDS Soc"},{"year":"2012","series-title":"PEPFAR blueprint: creating an AIDS-free generation","author":"Office of the Global AIDS Coordinator","key":"10.1016\/j.contraception.2018.02.002_bb0085"},{"issue":"11","key":"10.1016\/j.contraception.2018.02.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013868","article-title":"Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services","volume":"5","author":"Kaida","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2018.02.002_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2458-12-197","article-title":"Factors impacting knowledge and use of long acting and permanent contraceptive methods by postpartum HIV positive and negative women in Cape Town, South Africa: a cross-sectional study","volume":"12","author":"Cred\u00e9","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.contraception.2018.02.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036039","article-title":"High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa","volume":"7","author":"Schwartz","year":"2012","journal-title":"PLoS One"},{"year":"2014","series-title":"Policy brief: the Global Fund supports reproductive health commodity security","author":"USAID Deliver Project","key":"10.1016\/j.contraception.2018.02.002_bb0105"},{"key":"10.1016\/j.contraception.2018.02.002_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5582\/bst.2011.v5.6.255","article-title":"High rate of unintended pregnancies after knowing of HIV infection among HIV positive women under antiretroviral treatment in Kigali, Rwanda","volume":"5","author":"Kikuchi","year":"2011","journal-title":"Biosci Trends"},{"key":"10.1016\/j.contraception.2018.02.002_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1758-2652-14-35","article-title":"Uptake of family planning methods and unplanned pregnancies among HIV-infected individuals: a cross-sectional survey among clients at HIV clinics in Uganda","volume":"14","author":"Wanyenze","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.contraception.2018.02.002_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1468-1293.2011.00946.x","article-title":"Ontario HIV Fertility Research Team. High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study","volume":"13","author":"Loutfy","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.contraception.2018.02.002_bb0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1521\/aeap.2011.23.4.313","article-title":"Women's and men's fertility preferences and contraceptive behaviors by HIV status in 10 sub-Saharan African countries","volume":"23","author":"Bankole","year":"2011","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.contraception.2018.02.002_bb0130","article-title":"Differences in the nonuse of any contraception and use of specific contraceptive methods in HIV positive and HIV negative Rwandan women","volume":"2012","author":"Adedimeji","year":"2012","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.contraception.2018.02.002_bb0135","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10461-008-9365-5","article-title":"Family planning among HIV positive and negative prevention of mother to child transmission (PMTCT) clients in a resource poor setting in South Africa","volume":"13","author":"Peltzer","year":"2009","journal-title":"AIDS Behav"},{"key":"10.1016\/j.contraception.2018.02.002_bb0140","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00126334-200308150-00010","article-title":"Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states","volume":"33","author":"Wilson","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2018.02.002_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/809682","article-title":"Fertility intentions and interest in integrated family planning services among women living with HIV in Nyanza Province, Kenya: a qualitative study","volume":"2012","author":"Harrington","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.02.002_bb0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s10461-010-9848-z","article-title":"Influence of culture on contraceptive utilization among HIV-positive women in Brazil, Kenya, and South Africa","volume":"15","author":"Todd","year":"2011","journal-title":"AIDS Behav"},{"issue":"4","key":"10.1016\/j.contraception.2018.02.002_bb0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.contraception.2011.09.005","article-title":"Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz","volume":"85","author":"Leticee","year":"2012","journal-title":"Contraception"},{"issue":"17","key":"10.1016\/j.contraception.2018.02.002_bb0160","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1097\/QAD.0000000000000827","article-title":"Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy","volume":"29","author":"Pyra","year":"2015","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.contraception.2018.02.002_bb0165","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/QAD.0000000000001392","article-title":"Drug interactions between hormonal contraceptives and antiretrovirals: a systematic review","volume":"31","author":"Nanda","year":"2017","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2018.02.002_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10461-009-9544-z","article-title":"A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa","volume":"13","author":"Laher","year":"2009","journal-title":"AIDS Behav"},{"key":"10.1016\/j.contraception.2018.02.002_bb0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.contraception.2009.12.010","article-title":"Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa","volume":"81","author":"Laher","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.02.002_bb0180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/cid\/civ1001","article-title":"Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation over 48 weeks","volume":"62","author":"Scarsi","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.contraception.2018.02.002_bb0185","doi-asserted-by":"crossref","first-page":"528","DOI":"10.9745\/GHSP-D-15-00356","article-title":"Reduced effectiveness of contraceptive implants for women taking the antiretroviral efavirenz (EFV): still good enough and for how long?","volume":"3","author":"Shelton","year":"2015","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.contraception.2018.02.002_bb0190","series-title":"Abstract 938, conference on retroviruses and opportunistic infections (CROI)","article-title":"IMPAACT P1026s protocol team. Interaction between etonogestrel-releasing implant and 3 antiretroviral regimens","author":"Kreitchmann","year":"2017"},{"issue":"4","key":"10.1016\/j.contraception.2018.02.002_bb0195","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/QAI.0000000000000189","article-title":"Effect of antiretroviral therapy including lopinavir\/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women","volume":"66","author":"Vieira","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.contraception.2018.02.002_bb0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/13625187.2016.1177718","article-title":"Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir\/ritonavir-based antiretroviral therapy","volume":"21","author":"Ragazini","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.02.002_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.contraception.2018.02.002_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0197-2456(94)00031-W","article-title":"Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists","volume":"16","author":"Moher","year":"1995","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.contraception.2018.02.002_bb0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.contraception.2018.02.002_bb0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2018.02.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010243.pub2","article-title":"Interventions for improving contraceptive use among women living with HIV","volume":"1","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2018.02.002_bb0230","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.contraception.2010.09.003","article-title":"Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand","volume":"83","author":"Nanda","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.02.002_bb0235","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/QAI.0b013e318293df9e","article-title":"Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe","volume":"63","author":"Bengtson","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2018.02.002_bb0240","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2007.03.031","article-title":"A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus","volume":"197","author":"Stringer","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.02.002_bb0245","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/QAD.0b013e32832cbca8","article-title":"HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial","volume":"23","author":"Stringer","year":"2009","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.contraception.2018.02.002_bb0250","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/AOG.0000000000001087","article-title":"Intrauterine contraception among women living with human immunodeficiency virus: a randomized controlled trial","volume":"126","author":"Kakaire","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2018.02.002_bb0255","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/13625187.2016.1146249","article-title":"Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial","volume":"21","author":"Kakaire","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.02.002_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1054-139X(01)00282-8","article-title":"Adolescent medicine HIV\/AIDS research network. Contraceptive choices in HIV infected and HIV at-risk adolescent females","volume":"29","author":"Belzer","year":"2001","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.contraception.2018.02.002_bb0265","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2334-11-144","article-title":"To use or not to use a condom: a prospective cohort study comparing contraceptive practices among HIV-infected and HIV-negative youth in Uganda","volume":"11","author":"Beyeza-Kashesya","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.contraception.2018.02.002_bb0270","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.contraception.2013.08.006","article-title":"Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate","volume":"88","author":"Haddad","year":"2013","journal-title":"Contraception"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2018.02.002_bb0275","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/QAD.0000000000000039","article-title":"Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia","volume":"27","author":"Haddad","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2018.02.002_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2012.10.017","article-title":"Factors associated with the use of irreversible contraception and continuous use of reversible contraception in a cohort of HIV-positive women","volume":"88","author":"Kancheva Landolt","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.02.002_bb0285","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/jwh.2006.0238","article-title":"Contraception among HIV concordant and discordant couples in Zambia: a randomized controlled trial","volume":"16","author":"Mark","year":"2007","journal-title":"J Women's Health (Larchmt)"},{"key":"10.1016\/j.contraception.2018.02.002_bb0290","first-page":"784","article-title":"Is the intrauterine device appropriate contraception for HIV-1-infected women?","volume":"108","author":"Morrison","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2018.02.002_bb0295","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.contraception.2013.11.008","article-title":"Members of the Rakai Health Sciences Program Sayana Press study team. Preference for Sayana\u00ae Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial","volume":"89","author":"Polis","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.02.002_bb0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.olq.0000218880.88179.36","article-title":"High uptake of postpartum hormonal contraception among HIV-1-seropositive women in Kenya","volume":"34","author":"Balkus","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.contraception.2018.02.002_bb0305","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31828decf8","article-title":"Effect of the levonorgestrel intrauterine device on genital HIV-1 RNA shedding among HIV-1-infected women not taking antiretroviral therapy in Nairobi, Kenya","volume":"63","author":"Coleman","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2018.02.002_bb0310","doi-asserted-by":"crossref","first-page":"126.e1","DOI":"10.1016\/j.ajog.2010.09.002","article-title":"The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study","volume":"204","author":"Heikinheimo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.02.002_bb0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijgo.2011.12.002","article-title":"Safety and efficacy of contraceptive implants for HIV-infected women in Porto Alegre, Brazil","volume":"117","author":"Kreitchmann","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2018.02.002_bb0320","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/09540121.2012.752786","article-title":"Uptake and continuous use of copper intrauterine device in a cohort of HIV-positive women","volume":"25","author":"Landolt","year":"2013","journal-title":"AIDS Care"},{"key":"10.1016\/j.contraception.2018.02.002_bb0325","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0010-7824(01)00216-5","article-title":"Use of Norplant implants in the immediate postpartum period among asymptomatic HIV-1-positive mothers","volume":"64","author":"Taneepanichskul","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.02.002_bb0330","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e31827ee19c","article-title":"Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia","volume":"63","author":"Wall","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2018.02.002_bb0335","doi-asserted-by":"crossref","first-page":"72","DOI":"10.9745\/GHSP-D-13-00116","article-title":"Scaling up delivery of contraceptive implants in sub-Saharan Africa: operational experiences of Marie Stopes International","volume":"2","author":"Duvall","year":"2014","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.contraception.2018.02.002_bb0340","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2105\/AJPH.2007.129528","article-title":"Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda","volume":"99","author":"Andia","year":"2009","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.contraception.2018.02.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063411","article-title":"Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda","volume":"8","author":"Kaida","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.contraception.2018.02.002_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004149","article-title":"Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study","volume":"4","author":"Homsy","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2018.02.002_bb0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2013.11.002","article-title":"Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan","volume":"89","author":"Lendvay","year":"2014","journal-title":"Contraception"},{"year":"2012","series-title":"Key data and findings: contraceptive commodities for women's health","author":"United Nations Commission on Life-saving Commodities for Women and Children","key":"10.1016\/j.contraception.2018.02.002_bb0360"},{"key":"10.1016\/j.contraception.2018.02.002_bb0370","first-page":"2","article-title":"Female sterilization in Thailand: past, present and future","volume":"76","author":"Intaraprasert","year":"1993","journal-title":"J Med Assoc Thail"},{"issue":"3","key":"10.1016\/j.contraception.2018.02.002_bb0380","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.socscimed.2004.12.011","article-title":"The impact of health care providers on female sterilization among HIV-positive women in Brazil","volume":"61","author":"Hopkins","year":"2005","journal-title":"Soc Sci Med"},{"issue":"11","key":"10.1016\/j.contraception.2018.02.002_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164887","article-title":"Differences in the access to sterilization between women living and not living with HIV: results from the GENIH study, Brazil","volume":"11","author":"Barbosa","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.contraception.2018.02.002_bb0390","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.socscimed.2007.03.019","article-title":"\"life is still going on\": reproductive intentions among HIV-positive women and men in South Africa","volume":"65","author":"Cooper","year":"2007","journal-title":"Soc Sci Med"},{"issue":"6","key":"10.1016\/j.contraception.2018.02.002_bb0395","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.socscimed.2009.06.002","article-title":"The reproductive needs and rights of people living with HIV in Argentina: health service users' and providers' perspectives","volume":"69","author":"Gogna","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.contraception.2018.02.002_bb0400","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/QAD.0b013e32834f981c","article-title":"Partners in Prevention HSVHIV Transmission Study Team. Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships","volume":"26","author":"Ngure","year":"2012","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.contraception.2018.02.002_bb0405","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(15)00184-8","article-title":"Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study","volume":"2","author":"Patel","year":"2015","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.contraception.2018.02.002_bb0410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/QAI.0000000000000848","article-title":"Hormonal contraception, pregnancy, breastfeeding, and risk of HIV disease progression among Zambian women","volume":"71","author":"Wall","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2018.02.002_bb0415","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/OLQ.0b013e3181e1a162","article-title":"Partners in Prevention HSV\/HIV Transmission Study Team. A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships","volume":"37","author":"Heffron","year":"2010","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.contraception.2018.02.002_bb0420","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jfprhc-2011-0109","article-title":"Impact of learning HIV status on contraceptive use in the MIRA trial","volume":"37","author":"Blanchard","year":"2011","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2018.02.002_bb0425","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.contraception.2015.07.003","article-title":"Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness","volume":"93","author":"Whiteman","year":"2016","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2018.02.002_bb0430","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAD.0b013e32835ad473","article-title":"Partners in prevention HSVHIV transmission study team. Hormonal contraceptive use and risk of HIV-1 disease progression","volume":"27","author":"Heffron","year":"2013","journal-title":"AIDS"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418300532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418300532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:10:42Z","timestamp":1762117842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782418300532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0010782418300532"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2018.02.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of contraceptive continuation among women living with HIV","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}